Characteristics of Analyzed Patients
| Demographic | n = 61 |
| Age (y) | |
| Median | 57 |
| Range | 29–80 |
| Sex | |
| Male | 36 (59) |
| Female | 25 (41) |
| Ann Arbor Stage | |
| I–II | 41 (67.2) |
| III–IV | 20 (32.8) |
| B symptom | 7 (11.5) |
| Extranodal involvement ≥ 2 | 9 (14.8) |
| Bone marrow involvement | 3 (4.9) |
| Lactate dehydrogenase* (IU/mL) | |
| Mean | 239 |
| Range | 122–1,829 |
| IPI | |
| Low | 37 (60.7) |
| Low-intermediate | 11 (18) |
| High-intermediate | 11 (18) |
| High | 2 (3.3) |
| Ki 67 (%) | |
| Median | 50 |
| Range | 5–95 |
| Diagnosis | |
| DLBL | 50 (82) |
| Mantle cell lymphoma | 4 (6.6) |
| Follicular lymphoma | 1 (1.6) |
| Burkitt lymphoma | 1 (1.6) |
| Extranodal natural killer/T cell lymphoma, nasal type | 4 (6.6) |
| Peripheral T cell lymphoma, NOS | 1 (1.6) |
↵* Reference range for lactate dehydrogenase is 101–202 IU/mL.
Data in parentheses are percentages.